Also trades as: 0HC7.L (LSE) · $vol 0M

$98.96

+5.54 (+5.93%)

Weekly Expected Move ±3.2%

$88 $91 $94 $97 $100

NYSE · Basic Materials · Chemicals - Specialty · Tech Score Sell · Power 40 · $11.7B mcap · 118M float · 2.02% daily turnover · Short 58% of daily vol

Credit Risk of going bust: higher than 53% of companies Debt: 14.5% of company value Bonds: none of note held by US funds details ▾

Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.80 (down 98%), Albemarle Corporation would be worth roughly what it owes.
Total debt $1.99B against a stock market value of $11.68B.
Distance to default 4.87 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $975.7M (short-term plus half of long-term), stock volatility 54.9%; Altman Z 2.39. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$5.1B -4.4% ▼

5Y CAGR: +10.4%

Gross Profit

$672M +1014.9% ▲

5Y CAGR: -7.6%

Operating Income

$94M +114.7% ▲

5Y CAGR: -28.6%

Net Income

-$511M +56.7% ▲

EPS (Diluted)

$-5.75 +48.7% ▲

EBITDA

$754M +1773.8% ▲

5Y CAGR: +0.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$3.3B	$7.3B	$9.6B	$5.4B	$5.1B
YoY Growth	+6.4%	+120.0%	+31.4%	-44.1%	-4.4%
Cost of Revenue	$2.3B	$4.2B	$8.4B	$5.3B	$4.5B
Gross Profit	$1.0B	$3.1B	$1.2B	$84M	$672M
Gross Margin	30.3%	42.0%	12.4%	1.6%	13.1%
R&D Expenses	$54M	$72M	$86M	$87M	$51M
SG&A Expenses	$0	$0	$0	$0	$526M
Operating Expenses	$210M	$608M	$945M	$1.9B	$578M
Operating Income	$798M	$2.5B	$252M	-$1.8B	$94M
Operating Margin	24.0%	33.7%	2.6%	-33.0%	1.8%
Interest Expense	$61M	$123M	$116M	$166M	$208M
Income Before Tax	$229M	$3.2B	$2.1B	-$1.0B	-$308M
Tax Expense	$29M	$391M	$430M	$87M	$157M
Net Income	$124M	$2.7B	$1.6B	-$1.2B	-$511M
Net Margin	3.7%	36.7%	16.4%	-21.9%	-9.9%
EPS (Diluted)	$1.06	$22.84	$13.36	$-11.20	$-5.75
EBITDA	$875M	$2.9B	$897M	-$9M	$754M
Shares Outstanding	117M	118M	118M	118M	118M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.4B	$1.2B	$1.1B	$1.3B	$1.3B	$1.4B	$1.4B	$1.7B
Cost of Revenue	$1.5B	$1.1B	$921M	$1.1B	$1.2B	$1.2B	$928M	$1.2B
Gross Profit	-$104M	$138M	$156M	$197M	$118M	$203M	$501M	$590M
Gross Margin	-7.7%	11.2%	14.5%	14.8%	9.0%	14.2%	35.1%	33.9%
R&D Expenses	$22M	$20M	$14M	$12M	$13M	$12M	$9M	$4M
SG&A Expenses	$154M	$136M	$124M	$132M	$135M	$142M	$137M	$126M
Operating Expenses	$1.0B	$134M	$137M	$149M	$148M	$154M	$267M	$137M
Operating Income	-$1.1B	$4M	$20M	$48M	-$30M	$48M	$234M	$453M
Operating Margin	-81.9%	0.4%	1.8%	3.6%	-2.3%	3.4%	16.3%	26.0%
Interest Expense	$48M	$45M	$49M	$50M	$51M	$58M	$33M	$31M
Income Before Tax	-$950M	$96M	-$19M	$69M	-$179M	-$244M	$254M	$442M
Tax Expense	$111M	$11M	-$4M	$34M	-$31M	$157M	$22M	-$58M
Net Income	-$1.1B	$75M	$41M	$23M	-$161M	-$414M	$319M	$480M
Net Margin	-78.9%	6.1%	3.8%	1.7%	-12.3%	-29.0%	22.3%	27.5%
EPS (Diluted)	$-9.45	$0.29	$-0.00	$-0.16	$-1.72	$-3.87	$2.34	$3.22
EBITDA	-$968M	$285M	$192M	$210M	$134M	-$23M	$445M	$620M
Shares Outstanding	118M	118M	118M	118M	118M	118M	119M	136M

ALB NYSE